vs

Side-by-side financial comparison of SHENANDOAH TELECOMMUNICATIONS CO (SHEN) and Vericel Corp (VCEL). Click either name above to swap in a different company.

Vericel Corp is the larger business by last-quarter revenue ($92.9M vs $91.6M, roughly 1.0× SHENANDOAH TELECOMMUNICATIONS CO). Vericel Corp runs the higher net margin — 25.0% vs -5.9%, a 30.9% gap on every dollar of revenue. On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 7.2%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $-78.6M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 15.0%).

Shenandoah Telecommunications Co is a U.S. regional telecom provider offering broadband internet, wireless voice/data services, digital cable TV, and fiber-optic solutions. It serves residential, small business and enterprise clients across Mid-Atlantic states, focusing on underserved rural and suburban markets in Virginia, West Virginia, Maryland and Pennsylvania.

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.

SHEN vs VCEL — Head-to-Head

Bigger by revenue
VCEL
VCEL
1.0× larger
VCEL
$92.9M
$91.6M
SHEN
Growing faster (revenue YoY)
VCEL
VCEL
+16.0% gap
VCEL
23.3%
7.2%
SHEN
Higher net margin
VCEL
VCEL
30.9% more per $
VCEL
25.0%
-5.9%
SHEN
More free cash flow
VCEL
VCEL
$91.4M more FCF
VCEL
$12.8M
$-78.6M
SHEN
Faster 2-yr revenue CAGR
VCEL
VCEL
Annualised
VCEL
34.6%
15.0%
SHEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SHEN
SHEN
VCEL
VCEL
Revenue
$91.6M
$92.9M
Net Profit
$-5.4M
$23.2M
Gross Margin
78.7%
Operating Margin
-1.0%
24.1%
Net Margin
-5.9%
25.0%
Revenue YoY
7.2%
23.3%
Net Profit YoY
-95.8%
17.3%
EPS (diluted)
$-0.13
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SHEN
SHEN
VCEL
VCEL
Q4 25
$91.6M
$92.9M
Q3 25
$89.8M
$67.5M
Q2 25
$88.6M
$63.2M
Q1 25
$87.9M
$52.6M
Q4 24
$85.4M
$75.4M
Q3 24
$87.6M
$57.9M
Q2 24
$85.8M
$52.7M
Q1 24
$69.2M
$51.3M
Net Profit
SHEN
SHEN
VCEL
VCEL
Q4 25
$-5.4M
$23.2M
Q3 25
$-9.4M
$5.1M
Q2 25
$-9.0M
$-553.0K
Q1 25
$-9.1M
$-11.2M
Q4 24
$-2.7M
$19.8M
Q3 24
$-5.3M
$-901.0K
Q2 24
$-12.9M
$-4.7M
Q1 24
$214.7M
$-3.9M
Gross Margin
SHEN
SHEN
VCEL
VCEL
Q4 25
78.7%
Q3 25
73.5%
Q2 25
73.7%
Q1 25
69.0%
Q4 24
77.6%
Q3 24
71.9%
Q2 24
69.5%
Q1 24
68.9%
Operating Margin
SHEN
SHEN
VCEL
VCEL
Q4 25
-1.0%
24.1%
Q3 25
-8.0%
5.1%
Q2 25
-10.3%
-3.2%
Q1 25
-6.9%
-24.3%
Q4 24
-6.7%
24.5%
Q3 24
-4.8%
-4.3%
Q2 24
-18.5%
-11.5%
Q1 24
-4.0%
-10.7%
Net Margin
SHEN
SHEN
VCEL
VCEL
Q4 25
-5.9%
25.0%
Q3 25
-10.5%
7.5%
Q2 25
-10.2%
-0.9%
Q1 25
-10.4%
-21.4%
Q4 24
-3.2%
26.3%
Q3 24
-6.0%
-1.6%
Q2 24
-15.0%
-8.9%
Q1 24
310.0%
-7.5%
EPS (diluted)
SHEN
SHEN
VCEL
VCEL
Q4 25
$-0.13
$0.46
Q3 25
$-0.20
$0.10
Q2 25
$-0.19
$-0.01
Q1 25
$-0.19
$-0.23
Q4 24
$-0.34
$0.40
Q3 24
$-0.13
$-0.02
Q2 24
$-0.24
$-0.10
Q1 24
$4.25
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SHEN
SHEN
VCEL
VCEL
Cash + ST InvestmentsLiquidity on hand
$27.3M
$137.5M
Total DebtLower is stronger
$642.4M
Stockholders' EquityBook value
$880.8M
$354.6M
Total Assets
$1.9B
$488.0M
Debt / EquityLower = less leverage
0.73×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SHEN
SHEN
VCEL
VCEL
Q4 25
$27.3M
$137.5M
Q3 25
$22.6M
$135.4M
Q2 25
$29.1M
$116.9M
Q1 25
$87.5M
$112.9M
Q4 24
$46.3M
$116.2M
Q3 24
$43.1M
$101.7M
Q2 24
$43.8M
$102.5M
Q1 24
$389.7M
$110.6M
Total Debt
SHEN
SHEN
VCEL
VCEL
Q4 25
$642.4M
Q3 25
$535.4M
Q2 25
$513.1M
Q1 25
$515.8M
Q4 24
$418.0M
Q3 24
$345.2M
Q2 24
$297.4M
Q1 24
$298.7M
Stockholders' Equity
SHEN
SHEN
VCEL
VCEL
Q4 25
$880.8M
$354.6M
Q3 25
$892.7M
$321.9M
Q2 25
$902.0M
$306.8M
Q1 25
$910.5M
$295.5M
Q4 24
$918.6M
$292.0M
Q3 24
$925.4M
$257.5M
Q2 24
$933.1M
$243.0M
Q1 24
$871.6M
$233.9M
Total Assets
SHEN
SHEN
VCEL
VCEL
Q4 25
$1.9B
$488.0M
Q3 25
$1.9B
$453.3M
Q2 25
$1.8B
$435.6M
Q1 25
$1.8B
$424.6M
Q4 24
$1.7B
$432.7M
Q3 24
$1.7B
$390.4M
Q2 24
$1.7B
$376.8M
Q1 24
$1.4B
$356.7M
Debt / Equity
SHEN
SHEN
VCEL
VCEL
Q4 25
0.73×
Q3 25
0.60×
Q2 25
0.57×
Q1 25
0.57×
Q4 24
0.46×
Q3 24
0.37×
Q2 24
0.32×
Q1 24
0.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SHEN
SHEN
VCEL
VCEL
Operating Cash FlowLast quarter
$28.8M
$15.0M
Free Cash FlowOCF − Capex
$-78.6M
$12.8M
FCF MarginFCF / Revenue
-85.8%
13.8%
Capex IntensityCapex / Revenue
117.2%
2.4%
Cash ConversionOCF / Net Profit
0.65×
TTM Free Cash FlowTrailing 4 quarters
$-257.9M
$24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SHEN
SHEN
VCEL
VCEL
Q4 25
$28.8M
$15.0M
Q3 25
$30.7M
$22.1M
Q2 25
$20.9M
$8.2M
Q1 25
$20.5M
$6.6M
Q4 24
$20.6M
$22.2M
Q3 24
$24.3M
$10.2M
Q2 24
$2.5M
$18.5M
Q1 24
$15.2M
$7.2M
Free Cash Flow
SHEN
SHEN
VCEL
VCEL
Q4 25
$-78.6M
$12.8M
Q3 25
$-51.4M
$19.5M
Q2 25
$-65.3M
$81.0K
Q1 25
$-62.7M
$-7.6M
Q4 24
$-72.0M
$8.5M
Q3 24
$-51.3M
$-9.2M
Q2 24
$-78.3M
$1.8M
Q1 24
$-54.9M
$-6.8M
FCF Margin
SHEN
SHEN
VCEL
VCEL
Q4 25
-85.8%
13.8%
Q3 25
-57.2%
28.8%
Q2 25
-73.7%
0.1%
Q1 25
-71.3%
-14.5%
Q4 24
-84.3%
11.2%
Q3 24
-58.5%
-15.9%
Q2 24
-91.3%
3.4%
Q1 24
-79.3%
-13.3%
Capex Intensity
SHEN
SHEN
VCEL
VCEL
Q4 25
117.2%
2.4%
Q3 25
91.4%
3.9%
Q2 25
97.3%
12.9%
Q1 25
94.7%
27.0%
Q4 24
108.4%
18.3%
Q3 24
86.2%
33.5%
Q2 24
94.2%
31.8%
Q1 24
101.2%
27.3%
Cash Conversion
SHEN
SHEN
VCEL
VCEL
Q4 25
0.65×
Q3 25
4.35×
Q2 25
Q1 25
Q4 24
1.12×
Q3 24
Q2 24
Q1 24
0.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SHEN
SHEN

Residential And SMB Incumbent Broadband$41.5M45%
Residential And SMB Glo Fiber Expansion Markets$23.0M25%
Commercial Fiber$20.3M22%
RLEC Other$6.8M7%

VCEL
VCEL

MACI Implants And Kits$84.1M90%
Other$8.8M10%

Related Comparisons